KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.315 $0.440 Friday, 26th Apr 2024 GLMD stock ended at $0.392. This is 0.229% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.87% from a day low at $0.373 to a day high of $0.395.
90 days $0.300 $0.466
52 weeks $0.260 $5.63

Historical Galmed Pharmaceuticals Ltd. prices

Date Open High Low Close Volume
Apr 12, 2016 $6.20 $6.80 $6.12 $6.47 72 912
Apr 11, 2016 $6.63 $6.65 $5.96 $6.03 56 203
Apr 08, 2016 $7.32 $7.32 $6.50 $6.70 105 023
Apr 07, 2016 $7.50 $7.54 $6.48 $7.38 156 650
Apr 06, 2016 $5.05 $7.72 $4.97 $7.33 419 211
Apr 05, 2016 $5.14 $5.43 $4.72 $5.06 23 181
Apr 04, 2016 $5.13 $5.67 $4.90 $5.35 125 417
Apr 01, 2016 $4.87 $5.24 $4.78 $5.05 16 270
Mar 31, 2016 $4.96 $5.24 $4.87 $4.93 19 503
Mar 30, 2016 $5.00 $5.35 $4.70 $5.09 96 980
Mar 29, 2016 $4.95 $4.95 $4.53 $4.65 41 400
Mar 28, 2016 $4.53 $5.14 $4.53 $4.79 87 900
Mar 24, 2016 $4.14 $4.50 $3.71 $4.44 20 300
Mar 23, 2016 $4.40 $4.48 $4.07 $4.07 16 100
Mar 22, 2016 $4.73 $4.90 $3.55 $4.46 26 000
Mar 21, 2016 $4.58 $4.80 $4.50 $4.73 73 500
Mar 18, 2016 $3.79 $4.50 $3.60 $4.50 121 800
Mar 17, 2016 $3.90 $3.99 $3.50 $3.76 65 900
Mar 16, 2016 $4.05 $4.21 $3.76 $3.88 43 600
Mar 15, 2016 $4.46 $4.65 $3.87 $3.98 66 800
Mar 14, 2016 $4.67 $4.89 $4.17 $4.42 38 900
Mar 11, 2016 $4.71 $5.03 $4.57 $4.75 8 000
Mar 10, 2016 $4.77 $4.87 $4.46 $4.59 57 400
Mar 09, 2016 $4.72 $4.75 $4.68 $4.71 2 300
Mar 08, 2016 $4.97 $4.97 $4.67 $4.67 20 000
Click to get the best stock tips daily for free!

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT